Journal of the Society for Cardiovascular Angiography & Interventions最新文献

{"title":"2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion","authors":"Andrew M. Goldsweig MD, MS, FSCAI ,&nbsp;Michael Glikson MD ,&nbsp;Jacqueline Joza MD ,&nbsp;Clifford J. Kavinsky MD, PhD, MSCAI ,&nbsp;Omar Khalique MD, FSCAI ,&nbsp;Dhanunjaya Lakkireddy MD ,&nbsp;G. Burkhard Mackensen MD, PhD, FSCAI ,&nbsp;Gerald V. Naccarelli MD ,&nbsp;Devi G. Nair MD ,&nbsp;Jacqueline Saw MD, FSCAI ,&nbsp;Rahul Prakash Sharma MD, FSCAI ,&nbsp;Matthew Sherwood MD, FSCAI ,&nbsp;Molly Szerlip MD, FSCAI ,&nbsp;Yngve Falck-Ytter MD ,&nbsp;Rebecca L. Morgan PhD, MPH ,&nbsp;Chelsea Armah MPH ,&nbsp;Scott Firestone MS ,&nbsp;Angela Fix MPH, MWC ,&nbsp;Emily Senerth MS, MPH ,&nbsp;Christopher R. Ellis MD","doi":"10.1016/j.jscai.2025.103783","DOIUrl":"10.1016/j.jscai.2025.103783","url":null,"abstract":"<div><h3>Background</h3><div>Left atrial appendage occlusion (LAAO) devices reduce the risk of atrial fibrillation-associated stroke relative to no oral anticoagulation. However, uncertainty and practice variation persist in the areas of patient selection, periprocedural imaging, adjunctive antithrombotic therapy, and management of peridevice leak (PDL) and device-related thrombus. The Society for Cardiovascular Angiography &amp; Interventions and Heart Rhythm Society developed these evidence-based guidelines to support clinicians, patients, and other stakeholders in management decisions regarding LAAO.</div></div><div><h3>Methods</h3><div>The Society for Cardiovascular Angiography &amp; Interventions and Heart Rhythm Society convened a balanced, multidisciplinary guideline panel with &lt;50% of members reporting significant conflicts of interest with the industry. Evidence Foundation, a registered 501(c)(3) nonprofit organization, provided methodological support for guideline development. The guideline panel formulated and prioritized clinical questions following the Grading of Recommendations Assessment, Development, and Evaluation approach in a population, intervention, comparison, outcome format. A technical review team of clinical and methodological experts conducted systematic reviews of the published evidence, synthesized data, and graded the certainty of evidence across outcomes. The guideline panel then developed recommendations and supporting statements informed by the technical review and using the Grading of Recommendations Assessment, Development, and Evaluation evidence-to-decision framework.</div></div><div><h3>Results</h3><div>The guideline panel developed 8 evidence-based recommendations to address variations in care related to LAAO. The panel also identified 2 knowledge gaps.</div></div><div><h3>Conclusions</h3><div>Key recommendations address patient selection for LAAO, periprocedural imaging, adjunctive antithrombotic therapy, and management of PDL and device-related thrombus. The panel also recommended necessary future research regarding the use of single antiplatelet therapy following LAAO and regarding the management of PDL.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103783"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expected Surgical Risk and the Risk of Stroke and Brain Injury After Transcatheter Aortic Valve Replacement: A Patient-Level Pooled Analysis","authors":"Steven R. Messé MD ,&nbsp;Daniel Grubman MD ,&nbsp;Mary E. Huerter MD ,&nbsp;Michael G. Dwyer III PhD ,&nbsp;Robert Zivadinov MD, PhD ,&nbsp;Cody Pietras BA ,&nbsp;Tamim M. Nazif MD ,&nbsp;Jeffrey W. Moses MD ,&nbsp;Tayyab Shah MD ,&nbsp;Louise Gambone RN ,&nbsp;Rishi Tripathi MBBS ,&nbsp;John K. Forrest MD ,&nbsp;Amit N. Vora MD, MPH ,&nbsp;Helen Parise ScD ,&nbsp;Alexandra J. Lansky MD","doi":"10.1016/j.jscai.2025.103867","DOIUrl":"10.1016/j.jscai.2025.103867","url":null,"abstract":"<div><h3>Background</h3><div>The 30-day Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) has been used to risk-stratify patients undergoing transcatheter aortic valve replacement (TAVR). Whether surgical mortality risk predicts stroke and neurocognitive outcomes following TAVR is unknown. We evaluated the association between STS-PROM and clinical outcomes, including stroke, acute brain injury on diffusion-weighted magnetic resonance imaging (DW-MRI), and cognitive decline in patients undergoing TAVR.</div></div><div><h3>Methods</h3><div>Patient-level data were pooled from 4 prospective trials: (1) DEFLECT III (N = 87), (2) NeuroTAVR (N = 44), (3) REFLECT I (N = 214), and (4) REFLECT II (N = 258). All studies included patients undergoing TAVR with a protocol-mandated predischarge DW-MRI and serial cognitive and neurologic assessments. All patients were evaluated by a board-certified neurologist at baseline, postprocedure, and 30 days. Clinical outcomes, including stroke, cognitive decline (Montreal Cognitive Assessment score), death, myocardial infarction, vascular, and bleeding complications were adjudicated by the same clinical events committee. Imaging analysis was performed by a single core laboratory using identical methods. The DW-MRI measures included total lesion number, individual lesion volume, and total lesion volume. Outcomes were compared between low (STS &lt;4), intermediate (STS 4-8), and high (STS &gt;8) risk groups.</div></div><div><h3>Results</h3><div>In total, 537 of 603 patients with DW-MRI and complete STS assessment undergoing transfemoral TAVR were included in this pooled analysis, of which 253 (47%) were low risk, 198 (37%) intermediate risk, and 86 (16%) high risk patients. At 30 days, high risk patients had higher rates of all-cause and cardiovascular mortality, myocardial infarction, acute kidney injury, bleeding, and vascular complications. Rates of stroke, disabling stroke, DW-MRI measures of brain injury, and cognitive decline were similar across risk categories.</div></div><div><h3>Conclusions</h3><div>This pooled analysis demonstrates that the STS score does not predict stroke, cognitive decline, or acute brain injury after TAVR.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103867"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radial Artery Avulsion During Peripheral Intervention Managed With a Nonsurgical Approach: Case Report","authors":"Matthew R. Holland MD ,&nbsp;Yolanda A. Ofori ,&nbsp;Michael A. Sola MD ,&nbsp;Stephen E. Dreyer MD ,&nbsp;Shea E. Hogan MD, MSCS","doi":"10.1016/j.jscai.2025.103815","DOIUrl":"10.1016/j.jscai.2025.103815","url":null,"abstract":"<div><div>Radial artery avulsion is an uncommon and serious complication of transradial artery approach, which is usually managed by vascular surgery. This case report describes an 81-year-old woman with radial artery avulsion during percutaneous lower extremity revascularization for symptomatic peripheral artery disease, which was managed using an endovascular approach. While holding manual pressure on the upper forearm, transfemoral access was obtained, and coils were delivered to the proximal radial artery, resulting in hemostasis. The patient’s subsequent course was uneventful and without clinical sequelae. Surgeons who perform transradial access should be familiar with potential complications and their associated management strategies to ensure safe patient care.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103815"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dr Dimitri Karmpaliotis—1971 to 2025","authors":"Raja Hatem MD","doi":"10.1016/j.jscai.2025.103861","DOIUrl":"10.1016/j.jscai.2025.103861","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103861"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cover","authors":"","doi":"10.1016/S2772-9303(25)01429-2","DOIUrl":"10.1016/S2772-9303(25)01429-2","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103983"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patent Ductus Arteriosus Occlusion in the Premature Infant: Persistent Research Gaps","authors":"Frank F. Ing MD ,&nbsp;Carl H. Backes MD","doi":"10.1016/j.jscai.2025.103878","DOIUrl":"10.1016/j.jscai.2025.103878","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103878"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fluoroscopic “Lucent Line” Visualization in SAPIEN 3 TAVR Deployment: Reproducibility and Impacts on Outcomes","authors":"Parasuram Krishnamoorthy MD ,&nbsp;Manish Vinayak MD ,&nbsp;Negar Salehi MD ,&nbsp;Sahil Khera MD, MPH ,&nbsp;Sunny Goel MD ,&nbsp;Amit Hooda MD ,&nbsp;Stamatios Lerakis MD, PhD ,&nbsp;Malcolm Anastasius MBBS, PhD ,&nbsp;George D. Dangas MD, PhD ,&nbsp;Pedro Moreno MD, PhD ,&nbsp;Samin K. Sharma MD ,&nbsp;Annapoorna S. Kini MD ,&nbsp;Gilbert H.L. Tang MD, MSc, MBA","doi":"10.1016/j.jscai.2025.103856","DOIUrl":"10.1016/j.jscai.2025.103856","url":null,"abstract":"<div><h3>Background</h3><div>Fluoroscopic radiolucent (lucent) line (LL) visualization in SAPIEN 3 (S3) transcatheter aortic valve replacement (TAVR) has been advocated to optimize implant depth, but reproducibility and outcomes remain unknown. Our goal was to determine the incidence of LL seen at conventional deployment view during S3 TAVR and associated outcomes.</div></div><div><h3>Methods</h3><div>From April 2017 to September 2022, fluoroscopic images of 1130 consecutive transfemoral S3 TAVR were retrospective analyzed. LL visualization at the time of S3 positioning (+ or −) and coaxiality (coaxial [C] or noncoaxial [NC]) of the S3 valve at final implantation in the 3-cusp coplanar view were respectively evaluated. Procedural and in-hospital outcomes per Valve Academic Research Consortium 3 definitions were determined.</div></div><div><h3>Results</h3><div>LL was present in only 64.8%, and coaxial implant was achieved in only 45.6% of the cases. Three main scenarios were identified: (1) LL(+)/C implant in 44.5%, (2) LL(+)/NC implant in 20.3%, and (3) LL(−)/NC implant in 34.2%. LL deployment resulted in a deeper S3 implantation (LL[+]/C: 19.8% ± 11.0% ventricular vs LL[+]/NC: 18.5% ± 9.7% vs LL[−]/NC: 17.5% ± 12.1%, at noncoronary cusp; <em>P</em> = .008; LL[+]/C 16.3 ± 11.5% vs LL[+]/NC: 15.6% ± 11.1% vs LL[−]/NC: 13.9% ± 13.5% at left-coronary cusp; <em>P</em> = .02). When comparing the 3 scenarios of S3 deployment, there were no differences in outcomes including paravalvular leak, pacemaker implantation, and hemodynamic performance.</div></div><div><h3>Conclusions</h3><div>LL visualization in S3 TAVR could not be obtained in a significant portion of cases, did not result in a coaxial valve deployment in a majority of cases, and did not achieve a higher valve implantation. However, no short-term clinical and echocardiographic impact was observed.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103856"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Destination, Not the Journey: Optimal Vessel Preparation to Prevent Recurrent In-Stent Restenosis After Brachytherapy","authors":"Samantha Espinosa MD, MPH ,&nbsp;Musa Sharkawi MBBCh ,&nbsp;Brian Bergmark MD","doi":"10.1016/j.jscai.2025.103875","DOIUrl":"10.1016/j.jscai.2025.103875","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103875"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Shockwave Versus Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Design and Rationale of the SHOCKIFY Trial","authors":"Sameh Sayfo MD ,&nbsp;Mohamad Bader Abo Hajar MD ,&nbsp;Taylor Pickering DO ,&nbsp;Kyle McCullough MD ,&nbsp;Cody Dorton DO ,&nbsp;Jasjit Banwait PhD ,&nbsp;Sarah Hale BS ,&nbsp;Ghadi Moubarak MD ,&nbsp;Colleen Parro BS ,&nbsp;Niat Tekle MPH ,&nbsp;Bonnie Ostergren MS ,&nbsp;Maya Elias BS ,&nbsp;Osniel Gonzalez Ramos BS ,&nbsp;J. Michael DiMaio MD ,&nbsp;Chadi Dib MD ,&nbsp;Mazin Foteh MD ,&nbsp;John Kedora MD","doi":"10.1016/j.jscai.2025.103865","DOIUrl":"10.1016/j.jscai.2025.103865","url":null,"abstract":"<div><h3>Background</h3><div>Calcified atherosclerotic disease in the lower extremities can lead to severe symptoms, including lifestyle-limiting claudication and chronic limb-threatening ischemia. Although surgical endarterectomy remains the gold standard treatment for symptomatic common femoral artery (CFA) stenosis, intravascular lithotripsy (IVL) combined with a drug-coated balloon (DCB) has shown potential as a safe and effective alternative. However, the long-term efficacy of this approach is not well-established.</div></div><div><h3>Methods</h3><div>The SHOCKwave angioplasty versus surgical endarterectomy for severe calcified common femoral artery stenosis: effIcacy/saFetY (SHOCKIFY) trial is a single-site, prospective, randomized clinical trial comparing IVL with DCB to surgical endarterectomy in the management of CFA stenosis. Eligible subjects will be randomized in a 1:1 manner to receive either IVL with DCB treatment or endarterectomy. The primary end points include 6-month safety, defined as freedom from perioperative death, major adverse cardiovascular events, and major adverse limb events, along with 1-year efficacy, measured by primary patency. Secondary end points include follow-up assessments at 30 days, 6 months, and 1 year for ankle-brachial index, Rutherford chronic limb-threatening ischemia classification, patient satisfaction, and quality of life metrics. Specifically, patency will be evaluated at 30 days and 6 months as part of the secondary end points. These metrics will be assessed through the Short Form-36 quality of life survey, the peripheral artery questionnaire, and the walking impairment questionnaire. Patient-reported outcomes will be analyzed at these follow-up intervals.</div></div><div><h3>Conclusions</h3><div>This trial aimed to assess whether IVL with DCB is a viable, noninferior alternative to the traditional surgical endarterectomy, potentially offering a safer, minimally invasive option for CFA stenosis. The results may reform the future of CFA treatment guidelines by providing robust, randomized data on the clinical utility of IVL in managing complex vascular calcification.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103865"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145099338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cerebral Embolic Protection Device Use, Stroke, and Disabling Stroke in TAVR Before and After PROTECTED-TAVR","authors":"Akiva Rosenzveig MD,&nbsp;Ankit Agrawal MD,&nbsp;Osamah Badwan MD,&nbsp;Grant Reed MD, MSc,&nbsp;Rishi Puri MD, PhD,&nbsp;Amar Krishnaswamy MD,&nbsp;Samir Kapadia MD","doi":"10.1016/j.jscai.2025.103722","DOIUrl":"10.1016/j.jscai.2025.103722","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103722"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}